Admission Date:  [**2135-10-16**]              Discharge Date:   [**2135-10-22**]   Service: MEDICINE  Allergies: Neurontin / Keflex / Bactrim  Attending:[**First Name3 (LF) 242**] Chief Complaint: L hip pain  Major Surgical or Invasive Procedure: L hip, femur ORIF   History of Present Illness: Briefly, Ms. [**Known lastname **] is a [**Age over 90 **] yo female with a history remarkable for HTN, DM type 2, atrial fibrillation s/p pacemaker placement, not on Coumadin [**3-2**] history of hemorrhagic CVA, now brought in from home following a fall.
X-rays consistent with left subcapital fracture and left mid shaft fracture, as well as osteopenia.
Given Morphine 1 mg IV X 3. .
She is currently undergoing investigation of multiple pulmonary nodules, and was scheduled for bronchoscopy on Monday with BAL for further eval.
Atrial fibrillation s/p pacemaker placement.
Planned for bronchoscopy with BAL on [**10-17**].
She ambulates with a walker at baseline.
Postoperative edema, emphysema and skin staples are noted.
R knee XRAY: Frontal and lateral views of the right knee demonstrate generalized osteopenia.
Hip/femoral fracture: The patient sustained a L femoral neck and comminuted midshaft fracture during her mechanical fall at home.
Pain control was achieved with morphine.
The patient could not get a right knee MRI due to her pacemaker.
Lovenox was used for postoperative DVT prophylaxis, and should be continued for 6 weeks postoperatively.
Pain control was acheieved on discharge with Percocet.
The patient was judged to be a large aspiration risk as well, and so Levaquin and Flagyl were started.
DM type 2: The patient's outpatient oral hypoglycemic regimen was held on admission, and the patient was placed on a regular insulin sliding scale.
The patient had good glucose control on this regimen during her hospitalization.
The patient was restarted on her usual outpatient oral regimen on discharge.
Cardiovascular: The patient was continued on her home regimen of [**Last Name (LF) 17339**], [**First Name3 (LF) **], and lopressor during her stay.
Because she received several units of blood and IV hydration in the early postoperative period, IV lasix was used to maintain slightly negative I/O ratio.
Amiodarone was continued per her usual outpatient regimen.
No changes were made to her regimen during her stay.
Medications on Admission: Glyburide 1.25 mg PO QAM FeSO4 325 mg PO BID [**First Name3 (LF) **] 20 mg PO QAM Lopressor 12.5 mg PO BID Avandia 4 mg PO QD Lasix 20 mg PO QAM Amiodarone 200 mg PO QAM Aspirin 325 mg PO QAM Tylenol qAM Timolol 0.5% 1 drop left eye qAM Xalatan 0.5% 2 drops OU qHS Albuterol MDI 2 puffs [**Hospital1 **]   Discharge Medications: 1.
Ferrous Sulfate 325 (65) mg Tablet Sig: One (1) Tablet PO BID (2 times a day).
Atorvastatin 20 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).
Metoprolol Tartrate 25 mg Tablet Sig: 0.5 Tablet PO BID (2 times a day).
Furosemide 20 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).
Amiodarone 200 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).
Albuterol 90 mcg/Actuation Aerosol Sig: Two (2) Puff Inhalation [**Hospital1 **] (2 times a day).
Latanoprost 0.005 % Drops Sig: One (1) Drop Ophthalmic  HS (at bedtime).
Oxycodone-Acetaminophen 5-325 mg Tablet Sig: 1-2 Tablets PO Q4-6H (every 4 to 6 hours) as needed for pain.
Acetaminophen 325 mg Tablet Sig: 1-2 Tablets PO Q4-6H (every 4 to 6 hours) as needed.
Levofloxacin 250 mg Tablet Sig: One (1) Tablet PO Q24H (every 24 hours) for 5 days.
Metronidazole 500 mg Tablet Sig: One (1) Tablet PO TID (3 times a day) for 5 days.
Enoxaparin 30 mg/0.3 mL Syringe Sig: One (1) 30mL syringe Subcutaneous Q24H (every 24 hours): Please continue for a total of 6 weeks postoperatively.
Avandia 4 mg Tablet Sig: One (1) Tablet PO once a day.
Glyburide 1.25 mg Tablet Sig: One (1) Tablet PO once a day.
